Clinical Trials Browser

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Endometrial Neoplasms

NCT00086567 2026-04-08

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

Completed

119 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms

NCT07514494 2026-04-07

PrimPIPAC

Phase 2 Recruiting

160 enrolled

Gynecologic

Peritoneal Neoplasms

NCT01226394 2026-04-06

ProphyloCHIP

Phase 3 Completed

150 enrolled

Gynecologic

Krukenberg Tumor, Peritoneal Neoplasms

NCT07493876 2026-04-03

EPICH

Phase NA Recruiting

300 enrolled

Gynecologic

Peritoneal Neoplasms

NCT04498117 2026-04-01

FLORA-5

Phase 3 Active not recruiting

615 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Phase 2 Recruiting

100 enrolled

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT07241091 2026-03-30

SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery

Phase NA Completed

60 enrolled 16 charts

Gynecologic

Intestinal Obstruction, Ovarian Neoplasms, Peritoneal Neoplasms

NCT07493421 2026-03-25

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

Phase NA Recruiting

20 enrolled

GastrointestinalGynecologic

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms

NCT02758951 2026-03-24

CAIRO6

Phase 2/3 Active not recruiting

358 enrolled

GastrointestinalGynecologic

Hyperthermia, Colonic Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT07001748 2026-03-23

STOPGAP II

Phase 2/3 Recruiting

148 enrolled

Gynecologic

Peritoneal Neoplasms

NCT07487168 2026-03-23

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

Phase 1 Not yet recruiting

24 enrolled

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Colorectal Neoplasms

NCT07478107 2026-03-20

OSNA

Completed

108 enrolled

Gynecologic

Peritoneal Neoplasms

Clinical Trials

Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis

FRAmework-01

Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

PrimPIPAC

ProphyloCHIP

EPICH

FLORA-5

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

CAIRO6

STOPGAP II

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

OSNA